IMR Press / CEOG / Volume 45 / Issue 6 / DOI: 10.12891/ceog4463.2018

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Original Research

Meaningful clinical information for impending rupture in tubal pregnancy

Show Less
1 Department of Obstetrics and Gynecology, College of Medicine, The Catholic University of Korea, Incheon St. Mary's Hospital, Incheon, Korea
2 Department of Obstetrics and Gynecology, College of Medicine, The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, Korea
Clin. Exp. Obstet. Gynecol. 2018, 45(6), 905–909; https://doi.org/10.12891/ceog4463.2018
Published: 10 December 2018
Abstract

Purpose of investigation: This study provides valuable information to help clinician’s decision for treatment modality that patients with tubal pregnancy are at risk for impending rupture. Materials and Methods: This was a retrospective study of patients diagnosed with tubal pregnancy between January 2001 and September 2010. The definite diagnosis of tubal pregnancy was confirmed intraoperatively. Results: This study recruited 495 women with tubal pregnancy. Of these, 162 (33.7%) had ruptured tubal pregnancies and 333 (67.3%) had unruptured tubal pregnancies. Multivariate logistic regression analysis revealed that gestational age > 8 weeks (odds ratio (OR): 4.69), beta-subunit human chorionic gonadotropin (ß-hCG, > 5,000 mIU/ml, OR: 2.43), and tubal mass size > 30 mm (OR: 12.09) were significant increased incidence for rupture of tubal pregnancy. Conclusion: The advanced gestational age is important factor, but the tubal mass size with elevated ß-hCG level were the more meaningful risk factors for rupture of tubal pregnancy.

Keywords
Measurable information
Rupture
Serum ß-hCG
Tubal mass size
Tubal pregnancy
Share
Back to top